Kuldip Sidhu
CEO
CEO & Founding Director Cell Therapeutics Pty Ltd
Australia
Biography
Kuldip Sidhu, PhD, BSC (Medical) is a stem cell expert at the Faculty of Medicine, University of New South Wales, Australia. His post doc training is from St Louis MO USA (1979-80) in assisted reproductive technology and he also worked with Prof James Thompson, Wisconsin USA (2000) who produced the first human embryonic stem cells in 1998. His research focus is on neural stem cells derived from both the embryonic and non-embryonic sources for developing future cell therapies for various neurodegenerative diseases, like Alzheimer’s, Parkinson’s and other neuronal diseases. He has established a state-of-the-art facility to study the cell and developmental biology of stem cells. The Stem Cell Lab (SCL) has expertise to culture, propagate, differentiate, engineer and transplant in animal models the neural stem cells. In addition, he has expertise in the derivation of new human embryonic stem cell lines including their clonal propagation. His lab was first to produce two hESC lines, Endeavour (E) 1 & 2 from Australia and E2 is listed on NIH registry USA for distribution. SCL has embarked on iPS Technology and produced over 100 iPSC clones from Alzheimer’s patients for studying the disease processes and drug discovery using genetic engineering and microarray technology.
Research Interest
Neurodegenerative Diseases, Endocrinology